Adipokines in bone disease

Elena Neumann,Susann Junker,Georg Schett,Klaus Frommer,Ulf Müller-Ladner
DOI: https://doi.org/10.1038/nrrheum.2016.49
IF: 32.286
2016-04-15
Nature Reviews Rheumatology
Abstract:Key PointsFactors derived from adipose tissue contribute to inflammation as well as to alterations to cartilage and boneExpression of adipokines is elevated in rheumatic diseases, both systemically and locally at sites of bone damageAdipokines not only have a proinflammatory effect in chronic inflammatory arthritis, but also affect bone remodelling in degenerative joint diseases such as osteoarthritisAdipokines are potential biomarkers of disease owing to their association with progression of bone erosions and osteophyte formationTargeting adipokine dysregulation presents future therapeutic options to modulate not only the immune response, but also cartilage and bone remodelling
rheumatology
What problem does this paper attempt to address?